A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AADAC | Arylacetamide deacetylase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AC004754.3 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000471331}; cDNA FLJ60496 {ECO:0000313|EMBL:BAG57772.1} | Predicted membrane proteins
| | | | | Group enriched |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
AC234582.1 | | Predicted intracellular proteins
| | | | | Tissue enriched |
AC234582.2 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ACSM6 | Acyl-CoA synthetase medium-chain family member 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AL021546.6 | Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial {ECO:0000313|Ensembl:ENSP00000229384} | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
AMTN | Amelotin | Predicted secreted proteins
| | | | | Group enriched |
ANKRD22 | Ankyrin repeat domain 22 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ANXA10 | Annexin A10 | Predicted intracellular proteins
| | | | | Tissue enriched |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | Predicted intracellular proteins
| | | | | Group enriched |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |